Patricia I Oteiza Selected Research

cyanidin

1/2022	Supplementation with cyanidin and delphinidin mitigates high fat diet-induced endotoxemia and associated liver inflammation in mice.
1/2022	A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy subjects.
1/2019	Anthocyanins protect the gastrointestinal tract from high fat diet-induced alterations in redox signaling, barrier integrity and dysbiosis.
1/2018	Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia I Oteiza Research Topics

Disease

17	Inflammation (Inflammations) 11/2022 - 08/2008
14	Insulin Resistance 01/2022 - 07/2012
12	Neoplasms (Cancer) 11/2022 - 10/2006
12	Neuroblastoma 01/2022 - 01/2002
7	Obesity 06/2020 - 07/2012
5	Necrosis 11/2022 - 11/2012
4	Endotoxemia 01/2022 - 01/2018
4	Hypertension (High Blood Pressure) 01/2021 - 07/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2019 - 04/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 07/2012
3	Iron Overload 01/2011 - 01/2002
3	Hodgkin Disease (Hodgkin's Disease) 07/2008 - 10/2006
2	Acute-Phase Reaction 01/2022 - 01/2017
2	Dysbiosis 01/2020 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 11/2013
2	Overweight 01/2019 - 01/2018
2	Kidney Neoplasms (Kidney Cancer) 01/2017 - 02/2011
2	Chronic Disease (Chronic Diseases) 01/2017 - 01/2016
2	Body Weight (Weight, Body) 01/2016 - 07/2015
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Fatty Liver 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Neuroinflammatory Diseases 06/2020
1	Hypertrophy 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Gestational Weight Gain 01/2017
1	Chronic Renal Insufficiency 01/2016
1	Proteinuria 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Colonic Neoplasms (Colon Cancer) 06/2014
1	Diabetes Mellitus 01/2014
1	Dementia (Dementias) 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014

Drug/Important Bio-Agent (IBA)

15	Catechin (Z 7300)IBA 01/2021 - 10/2006
12	ZincIBA 01/2022 - 01/2002
8	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2006
8	NF-kappa B (NF-kB)IBA 11/2009 - 09/2002
6	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 12/2011
5	LipidsIBA 01/2022 - 01/2018
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
5	Insulin (Novolin)FDA Link 01/2022 - 11/2012
5	FlavonoidsIBA 01/2021 - 07/2012
4	Oxidants (Oxidizing Agents)IBA 11/2022 - 11/2002
4	cyanidinIBA 01/2022 - 01/2018
4	Anthocyanins (Anthocyanin)IBA 01/2022 - 06/2014
4	delphinidinIBA 01/2022 - 01/2018
4	Proanthocyanidins (Procyanidins)IBA 01/2021 - 10/2006
4	flavan-3-olIBA 01/2020 - 01/2016
4	FructoseIBA 01/2018 - 07/2014
4	AldosteroneIBA 01/2017 - 02/2011
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022 - 01/2006
3	AntioxidantsIBA 01/2021 - 10/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
3	IronIBA 01/2011 - 01/2002
2	CurcuminIBA 11/2022 - 07/2008
2	Phosphotransferases (Kinase)IBA 01/2022 - 04/2015
2	MitogensIBA 01/2022 - 04/2015
2	Diethylhexyl Phthalate (DEHP)IBA 01/2022 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2020
2	EndotoxinsIBA 01/2020 - 01/2018
2	QuercetinIBA 01/2020 - 04/2015
2	ChemokinesIBA 12/2016 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 11/2012
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2016 - 11/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2015 - 11/2012
2	CytokinesIBA 07/2014 - 11/2013
2	Mitogen-Activated Protein KinasesIBA 11/2012 - 05/2006
1	lardIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	mono-(2-ethylhexyl)phthalateIBA 01/2022
1	phthalic acid (phthalate)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Ellagic AcidIBA 01/2020
1	GlycosidesIBA 01/2019
1	OccludinIBA 01/2019
1	MucinsIBA 01/2019
1	Claudin-1IBA 01/2019
1	PalmitatesIBA 01/2018
1	acetovanillone (apocynin)IBA 01/2018
1	CarbohydratesIBA 01/2018
1	MineralocorticoidsIBA 01/2017
1	SteroidsIBA 01/2017
1	procyanidinIBA 12/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2016
1	nephrinIBA 01/2016
1	Drinking WaterIBA 01/2016
1	Superoxides (Superoxide)IBA 07/2015
1	AdiponectinIBA 04/2015
1	3-O-methylgallic acidIBA 06/2014
1	PolyphenolsIBA 06/2014
1	2,4,6-trihydroxybenzaldehydeIBA 06/2014
1	Gallic AcidIBA 06/2014

Therapy/Procedure

2	Therapeutics 12/2011 - 04/2008